LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Unsecured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Unsecured Loans | ₹9.48 Cr | ₹36 Cr | ₹63 Cr | ₹62 Cr | ₹0.71 Cr |
What is the latest Unsecured Loans ratio of LYKA LABS ?
| Year | Unsecured Loans |
|---|---|
| Mar2025 | ₹9.48 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹63 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹0.71 Cr |
How is Unsecured Loans of LYKA LABS Trending?
| Years | Unsecured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.48 Cr | -73.46 | |
| Mar2024 | ₹36 Cr | -43.64 | |
| Mar2023 | ₹63 Cr | 2.88 | |
| Mar2022 | ₹62 Cr | 8,616.69 | |
| Mar2021 | ₹0.71 Cr | - | |
Compare Unsecured Loans of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹225.8 Cr | -7% | -16.2% | -45.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -7% |
-16.2% |
-45.7% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses